Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine

Maurizio Severino, Mithula Sivasaravanaparan, Louise Ø Olesen, Christian U von Linstow, Athanasios Metaxas, Elena V Bouzinova, Asif Manzoor Khan, Kate L Lambertsen, Alicia A Babcock, Jan Bert Gramsbergen, Ove Wiborg, Bente Finsen

Publikation: Bidrag til tidsskriftTidsskriftartikelForskningpeer review

6 Citationer (Scopus)
260 Downloads (Pure)
OriginalsprogEngelsk
TidsskriftAlzheimer's & Dementia
Vol/bind4
Sider (fra-til)215-223
Antal sider9
ISSN1552-5260
DOI
StatusUdgivet - 2018

    Fingerprint

Citationsformater

Severino, M., Sivasaravanaparan, M., Olesen, L. Ø., von Linstow, C. U., Metaxas, A., Bouzinova, E. V., Khan, A. M., Lambertsen, K. L., Babcock, A. A., Gramsbergen, J. B., Wiborg, O., & Finsen, B. (2018). Established amyloid-β pathology is unaffected by chronic treatment with the selective serotonin reuptake inhibitor paroxetine. Alzheimer's & Dementia, 4, 215-223. https://doi.org/10.1016/j.trci.2018.04.005